Breast Imaging

On this page

🎯 The Breast Imaging Arsenal: Multimodal Detection Mastery

Breast imaging demands fluency across mammography, ultrasound, and MRI-each revealing different tissue truths that together form a complete diagnostic picture. You'll master the BI-RADS lexicon to communicate findings precisely, recognize architectural distortions and mass characteristics that distinguish benign from malignant, and synthesize multimodal data to guide biopsy decisions and treatment planning. This lesson builds your pattern recognition skills and clinical judgment, transforming you from observer to diagnostic architect who confidently navigates screening, diagnosis, and therapeutic roadmaps.

📌 Remember: MUMS - Mammography (structure), Ultrasound (characterization), MRI (extent), Specimen radiography (confirmation). Each modality serves distinct diagnostic roles with 85-95% sensitivity ranges depending on breast density and lesion characteristics.

Primary Imaging Modalities Architecture

  • Mammography Foundation

    • Digital mammography: 98% of screening programs globally
    • Tomosynthesis (3D): 40% increase in cancer detection
      • Reduces recall rates by 15-20%
      • Improves specificity in dense breasts by 25%
    • Contrast-enhanced mammography: 88% sensitivity for invasive cancers
  • Ultrasound Characterization

    • Handheld ultrasound: 99% availability in breast centers
    • Automated whole-breast ultrasound: 3.7 additional cancers per 1000 screens
      • Particularly effective in BI-RADS C/D density categories
      • Reduces operator dependency by 60%
  • MRI Advanced Detection

    • Dynamic contrast-enhanced: 90-100% sensitivity for invasive cancers
    • Diffusion-weighted imaging: ADC values <1.3 × 10⁻³ mm²/s suggest malignancy
      • Reduces gadolinium requirements by 30%
      • Improves specificity to 85-90%
ModalityPrimary UseSensitivitySpecificityDensity LimitationCost Factor
Digital MammographyScreening/Diagnostic85-95%95-98%Decreases in dense tissue1x
TomosynthesisDense breast screening90-96%96-99%Minimal density impact1.5x
UltrasoundCharacterization95-100%85-95%Density independent0.5x
MRIHigh-risk screening90-100%85-90%Density independent8-10x
Contrast MammographyProblem-solving88-92%87-93%Moderate density impact2-3x

💡 Master This: Multimodal integration follows the "See-Think-Confirm" paradigm: mammography sees architectural distortion, ultrasound thinks about tissue characteristics, and MRI confirms extent of disease. This systematic approach reduces false-negative rates to <5% in comprehensive breast centers.

The foundation of breast imaging excellence lies in understanding when each modality provides maximum diagnostic value, setting the stage for exploring the sophisticated lexicon systems that standardize interpretation across all imaging platforms.

🎯 The Breast Imaging Arsenal: Multimodal Detection Mastery

🗣️ The BI-RADS Lexicon: Standardized Communication Mastery

📌 Remember: BIRADS - Benign findings, Intermediate concern, Recommendations clear, Assessment categories, Descriptors standardized, Systematic approach. Each component reduces interpretation variability by >90% compared to free-text reporting.

BI-RADS Category Framework

  • Assessment Categories (0-6)

    • Category 0: Incomplete assessment - additional imaging needed
      • Occurs in 8-12% of screening mammograms
      • 99% resolve to benign after diagnostic workup
    • Category 1: Negative - routine screening interval
      • Cancer probability: <0.1%
      • Annual screening recommendation
    • Category 2: Benign finding - routine screening interval
      • Cancer probability: <0.1%
      • Includes oil cysts, calcified fibroadenomas, lymph nodes
  • Actionable Categories (3-6)

    • Category 3: Probably benign - 6-month follow-up
      • Cancer probability: <2% (typically 0.5-1%)
      • Requires 2-year stability documentation
    • Category 4: Suspicious abnormality - tissue sampling
      • 4A: Low suspicion (2-10% malignancy)
      • 4B: Moderate suspicion (10-50% malignancy)
      • 4C: High suspicion (50-95% malignancy)
    • Category 5: Highly suggestive of malignancy - tissue sampling
      • Cancer probability: ≥95%
      • Requires immediate tissue diagnosis
    • Category 6: Known malignancy - treatment planning
      • 100% malignancy (biopsy-proven)
      • Used for staging and treatment response imaging

Modality-Specific Lexicon Integration

  • Mammographic Descriptors

    • Mass descriptors: Shape (oval, round, irregular), margin (circumscribed, obscured, microlobulated, indistinct, spiculated), density (fat, low, equal, high)
    • Calcification patterns: Typically benign (skin, vascular, coarse, large rod-like, round, rim, dystrophic, milk of calcium, suture) vs suspicious morphology (amorphous, coarse heterogeneous, fine pleomorphic, fine linear/branching)
      • Fine linear/branching: 70-90% malignancy probability
      • Amorphous: 20-25% malignancy probability
  • Ultrasound Lexicon Precision

    • Echo pattern: Anechoic, hyperechoic, isoechoic, hypoechoic, complex
    • Shape: Oval, round, irregular with parallel/not parallel orientation
    • Margin: Circumscribed, indistinct, angular, microlobulated, spiculated
      • Spiculated margins: 88% positive predictive value for malignancy
      • Circumscribed margins: <5% malignancy probability
BI-RADS CategoryCancer ProbabilityManagementFollow-up IntervalUpgrade RateTypical Findings
0VariableAdditional imagingImmediateN/AIncomplete study
1<0.1%Routine screening12 months<0.1%Normal study
2<0.1%Routine screening12 months<0.1%Benign findings
3<2%Short-term follow-up6 months0.5-2%Probably benign
4A2-10%Tissue samplingImmediate5-8%Low suspicion
4B10-50%Tissue samplingImmediate25-30%Moderate suspicion
4C50-95%Tissue samplingImmediate70-80%High suspicion
5≥95%Tissue samplingImmediate95-98%Highly suspicious
6100%Treatment planningVariable100%Known malignancy

💡 Master This: Lexicon consistency across modalities enables seamless communication between radiologists, surgeons, and oncologists. A spiculated mass carries the same high suspicion whether detected on mammography (PPV 88%) or ultrasound (PPV 85%), ensuring uniform clinical response regardless of detection method.

Understanding BI-RADS lexicon mastery provides the foundation for exploring how mammographic pattern recognition transforms subtle architectural changes into confident diagnostic assessments.

🗣️ The BI-RADS Lexicon: Standardized Communication Mastery

📸 Mammographic Pattern Recognition: The Architectural Detective

📌 Remember: MASS-CAL - Mass characteristics, Architectural distortion, Symmetry comparison, Special cases, Calcifications, Associated findings, Lymphatic assessment. This systematic approach reduces perceptual errors by 85% compared to random viewing patterns.

Mass Characterization Framework

  • Shape Analysis Hierarchy

    • Round/Oval masses: <5% malignancy probability
      • Circumscribed margins: 98% benign probability
      • High density: Consider fibroadenoma (70% of cases)
    • Irregular masses: 45-65% malignancy probability
      • Spiculated margins: 88% positive predictive value
      • Equal/low density: 75% invasive ductal carcinoma
  • Margin Assessment Precision

    • Circumscribed: Sharp, well-defined interface
      • >75% of margin visible: <5% malignancy risk
      • Lobulated contour: Consider phyllodes tumor or invasive lobular carcinoma
    • Spiculated: Radiating lines extending from mass
      • Classic sunburst pattern: 90% invasive carcinoma
      • Architectural distortion: 65% invasive ductal, 25% invasive lobular
Loading diagram…

Calcification Pattern Recognition

  • Benign Calcification Signatures

    • Vascular calcifications: Parallel tracks following vessel course
      • >90% in women >60 years
      • Bilateral and symmetric distribution
    • Coarse heterogeneous: >0.5mm irregular particles
      • Involuting fibroadenomas: Classic popcorn appearance
      • Fat necrosis: Rim calcifications with lucent centers
  • Suspicious Calcification Patterns

    • Fine pleomorphic: <0.5mm varying shapes
      • DCIS probability: 60-80% depending on distribution
      • Clustered pattern: >5 calcifications in 1cm³
    • Fine linear/branching: Casting-type calcifications
      • High-grade DCIS: 85-90% probability
      • Comedo necrosis: Branching Y-shaped patterns
Calcification TypeSize RangeMorphologyDistributionMalignancy RiskTypical Pathology
SkinVariableLucent centerDermal location0%Benign
VascularLinearParallel tracksVessel course0%Benign
Coarse heterogeneous>0.5mmIrregular chunksClustered/scattered<2%Fibroadenoma
Amorphous<0.5mmIndistinctClustered20-25%DCIS/invasive
Fine pleomorphic<0.5mmVarying shapesClustered/linear60-80%DCIS
Fine linear<0.5mmBranchingSegmental85-90%High-grade DCIS

💡 Master This: Bilateral comparison remains the cornerstone of mammographic interpretation. Developing asymmetry (new, larger, or more conspicuous than previous) carries 12-15% malignancy probability, while focal asymmetry (visible on only one projection) requires additional imaging in 85% of cases to exclude summation artifact.

Mammographic pattern mastery establishes the foundation for understanding how ultrasound characterization provides the definitive tissue analysis that transforms suspicious findings into confident diagnoses.

📸 Mammographic Pattern Recognition: The Architectural Detective

🔍 Ultrasound Characterization: The Tissue Truth Detector

📌 Remember: SHAPE-ME - Shape orientation, Hypoechogenicity, Acoustic features, Posterior enhancement, Echo pattern, Margin assessment, Elastography findings. This systematic approach achieves >95% diagnostic accuracy for solid versus cystic differentiation.

Solid Mass Characterization Matrix

  • Benign Solid Mass Features

    • Shape: Oval with parallel orientation (wider than tall)
      • Circumscribed margins: >75% of border well-defined
      • Homogeneous echogenicity: Uniform internal echo pattern
    • Acoustic properties: No posterior shadowing
      • Mild enhancement: 10-15% increase in through-transmission
      • Compressibility: >50% deformation with probe pressure
  • Malignant Solid Mass Indicators

    • Shape: Irregular with not parallel orientation (taller than wide)
      • Spiculated margins: Echogenic lines extending from mass
      • Heterogeneous echogenicity: Mixed echo patterns
    • Acoustic properties: Posterior acoustic shadowing
      • Marked hypoechogenicity: Darker than fat
      • Non-compressible: <20% deformation with pressure
Loading diagram…

Advanced Ultrasound Techniques

  • Elastography Assessment

    • Strain elastography: Qualitative stiffness assessment
      • Elasticity score 1-2: 95% benign probability
      • Elasticity score 4-5: 85% malignancy probability
    • Shear wave elastography: Quantitative measurements
      • <50 kPa: Benign lesions (90% specificity)
      • >80 kPa: Malignant lesions (85% sensitivity)
  • Doppler Evaluation Framework

    • Color Doppler: Vascular pattern assessment
      • Peripheral vascularity: Typical benign pattern
      • Central/chaotic flow: Suspicious for malignancy
    • Spectral Doppler: Quantitative flow analysis
      • RI <0.7: Benign lesions (80% specificity)
      • RI >0.8: Malignant lesions (75% sensitivity)
FeatureBenign CharacteristicsMalignant CharacteristicsSensitivitySpecificityPPV
ShapeOval, parallel orientationIrregular, not parallel85%92%75%
MarginCircumscribedSpiculated/angular78%88%65%
EchogenicityIsoechoic/hyperechoicHypoechoic82%85%70%
Posterior acousticEnhancement/no changeShadowing75%90%80%
ElastographySoft (score 1-2)Hard (score 4-5)88%83%72%

💡 Master This: Ultrasound-guided biopsy achieves >98% diagnostic accuracy when proper technique is employed. 14-gauge core biopsy with ≥5 samples provides adequate tissue for histologic and immunohistochemical analysis, while vacuum-assisted biopsy increases sample volume by 300% for calcified lesions.

Ultrasound characterization mastery provides the foundation for understanding how MRI's advanced capabilities reveal disease extent and guide treatment planning in complex clinical scenarios.

🔍 Ultrasound Characterization: The Tissue Truth Detector

⚖️ MRI Treatment Planning: The Multiparametric Navigator

📌 Remember: MRI-MAPS - Morphology assessment, Restricted diffusion, Initial enhancement, Mass characteristics, ADC values, Persistent/plateau/washout, Segmental distribution. This systematic approach achieves 85-90% specificity while maintaining >95% sensitivity.

Dynamic Contrast Enhancement Analysis

  • Kinetic Curve Classification

    • Type I (Persistent): Continuous enhancement throughout study
      • >90% benign probability
      • Fibroadenomas, papillomas: Classic persistent pattern
    • Type II (Plateau): Initial enhancement followed by stable signal
      • Intermediate suspicion: 30-40% malignancy probability
      • Requires morphologic correlation for final assessment
    • Type III (Washout): Rapid enhancement followed by signal decrease
      • >85% malignancy probability
      • Invasive ductal carcinoma: Classic washout pattern
  • Enhancement Threshold Analysis

    • Initial enhancement: >50% signal increase in first 2 minutes
      • Slow enhancement (<50%): Benign in 85% of cases
      • Rapid enhancement (>100%): Malignant in 75% of cases
    • Peak enhancement: Maximum signal intensity measurement
      • <100% enhancement: Low suspicion
      • >200% enhancement: High suspicion for malignancy
Loading diagram…

Diffusion-Weighted Imaging Integration

  • ADC Value Thresholds

    • Malignant lesions: ADC <1.3 × 10⁻³ mm²/s
      • Invasive ductal carcinoma: Mean ADC 0.9 × 10⁻³ mm²/s
      • High-grade DCIS: ADC 1.1-1.2 × 10⁻³ mm²/s
    • Benign lesions: ADC >1.5 × 10⁻³ mm²/s
      • Fibroadenomas: Mean ADC 1.8 × 10⁻³ mm²/s
      • Inflammatory changes: ADC >2.0 × 10⁻³ mm²/s
  • Treatment Response Monitoring

    • Neoadjuvant chemotherapy: ADC changes predict response
      • >25% ADC increase: Pathologic complete response in 70%
      • <10% ADC change: Residual disease in 85%
    • Size measurement accuracy: ±2mm correlation with pathology
      • Superior to mammography: 15-20% more accurate sizing
      • Surgical planning: Reduces positive margins by 30%
MRI ParameterBenign RangeMalignant RangeSensitivitySpecificityClinical Application
Initial Enhancement<50%>100%85%75%Lesion detection
Curve TypePersistentWashout90%85%Characterization
ADC Value>1.5 × 10⁻³<1.3 × 10⁻³88%82%Tissue analysis
Peak Enhancement<100%>200%82%78%Suspicion grading
Time to Peak>4 minutes<2 minutes75%80%Kinetic analysis

💡 Master This: Preoperative MRI changes surgical management in 15-25% of newly diagnosed breast cancer patients. Contralateral cancer detection occurs in 3-5% of cases, while ipsilateral multifocal/multicentric disease is identified in 20-30%, significantly impacting surgical planning and oncologic outcomes.

MRI mastery establishes the foundation for understanding how integrated multimodal approaches synthesize all imaging information into comprehensive diagnostic and treatment strategies.

⚖️ MRI Treatment Planning: The Multiparametric Navigator

🔗 Multimodal Integration: The Diagnostic Synthesis Engine

📌 Remember: INTEGRATE - Imaging correlation, Neoadjuvant monitoring, Tissue sampling guidance, Extent assessment, Genetic risk evaluation, Recurrence detection, Adjuvant planning, Treatment response, Emergent technologies. This systematic approach reduces diagnostic uncertainty by >90% compared to single-modality assessment.

Complementary Modality Synergy

  • Mammography-Ultrasound Integration

    • Mammographic detection → Ultrasound characterization
      • Architectural distortion: Ultrasound localizes in 85% of cases
      • Calcifications: Ultrasound correlation in 40-60% depending on size
    • Dense breast optimization: Combined sensitivity 95-98%
      • Mammography alone: 65-70% sensitivity in BI-RADS D density
      • Added ultrasound: Increases detection by 3-4 cancers per 1000 screens
  • MRI-Guided Treatment Planning

    • Extent of disease assessment: Changes surgery in 20-25% of cases
      • Breast conservation eligibility: MRI excludes 15% of candidates
      • Contralateral screening: Detects occult cancer in 3-5%
    • Neoadjuvant response monitoring: Predicts pathologic response
      • >50% size reduction: Correlates with pCR in 70%
      • ADC increase >25%: Predicts response in 80%
Loading diagram…

Emerging Technology Integration

  • Artificial Intelligence Enhancement

    • Computer-aided detection: Reduces reading time by 30-40%
      • Sensitivity improvement: 5-10% increase in cancer detection
      • Specificity maintenance: <2% increase in false-positive rate
    • Deep learning algorithms: Pattern recognition beyond human capability
      • Mammographic texture analysis: Predicts interval cancers
      • MRI kinetic modeling: Automated curve analysis with >95% accuracy
  • Molecular Imaging Applications

    • Contrast-enhanced mammography: Functional assessment without MRI
      • Sensitivity 85-90%: Comparable to MRI for invasive cancers
      • Cost-effective alternative: 30-40% of MRI cost
    • PET-MRI integration: Metabolic-morphologic correlation
      • Treatment response: Earlier detection than size changes
      • Recurrence detection: Higher specificity than MRI alone
Integration StrategyPrimary BenefitSensitivity GainSpecificity ImpactCost FactorClinical Application
Mammography + USDense breast screening+15-20%Maintained+50%Supplemental screening
Tomosynthesis + USArchitectural distortion+25-30%+5-10%+75%Diagnostic workup
MRI + MammographyExtent assessment+5-8%-10-15%+800%Preoperative staging
AI + MammographyReading efficiency+5-10%Maintained+20%Screening enhancement
CEM + USMRI alternative+10-15%+5-8%+200%Problem-solving

💡 Master This: Imaging-pathology concordance is essential for accurate diagnosis. Discordant results (imaging BI-RADS 4-5 with benign pathology) require repeat sampling or surgical consultation in >90% of cases, as upgrade rates to malignancy reach 15-25% in discordant scenarios.

Multimodal integration mastery provides the foundation for developing rapid clinical reference tools that synthesize complex imaging knowledge into immediately actionable diagnostic frameworks.

🔗 Multimodal Integration: The Diagnostic Synthesis Engine

🎯 Clinical Mastery Arsenal: Rapid Diagnostic Command Center

📌 Remember: RAPID-DX - Recognize patterns instantly, Assess with BI-RADS, Prioritize high-yield features, Integrate modalities, Determine management, Document systematically, X-check for concordance. This framework reduces diagnostic errors by >85% while maintaining efficiency.

Essential Clinical Thresholds

  • High-Yield Numerical Arsenal

    • Cancer Detection Rates: Screening 5-8 per 1000, Diagnostic 25-30%
    • BI-RADS Probabilities: Category 3 <2%, 4A 2-10%, 4B 10-50%, 4C 50-95%, 5 ≥95%
    • Modality Sensitivities: Mammography 85-95%, Ultrasound 95-100%, MRI 90-100%
    • Biopsy Yields: 14G core ≥5 samples, Vacuum 3x tissue volume, Concordance >90%
    • MRI Parameters: ADC <1.3 malignant, Washout curves 85% cancer, Enhancement >100% suspicious
  • Critical Decision Points

    • Dense Breast Supplemental: BI-RADS C/D requires additional screening
    • Architectural Distortion: 65% invasive cancer, tomosynthesis essential
    • Complex Cysts: Thick walls/septations >0.5mm = BI-RADS 4A
    • Discordant Results: Imaging 4-5 + benign path = repeat sampling
    • MRI-Only Lesions: 3-5% of cases, MRI-guided biopsy required
Clinical ScenarioKey ThresholdManagement ActionSuccess RateAlternative Approach
Screening Recall8-12% rateDiagnostic imaging99% benignPatient education
BI-RADS 3 Lesion<2% malignancy6-month follow-up98% stabilityConsider biopsy if anxious
Spiculated Mass88% malignantImmediate biopsy>95% diagnosticCore biopsy preferred
MRI Enhancement>100% initialKinetic analysis85% accuracyAdd DWI correlation
Discordant Path15-25% upgradeRepeat sampling>90% resolutionSurgical consultation

💡 Master This: Clinical correlation remains paramount in breast imaging. Family history, hormonal status, prior biopsies, and clinical examination findings can upgrade or downgrade imaging assessments by one BI-RADS category in 15-20% of cases, emphasizing the importance of comprehensive clinical integration.

🎯 Clinical Mastery Arsenal: Rapid Diagnostic Command Center

Unlock the full lesson and continue reading

Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more

Scan to download app

Scan to download
UNLOCK FREE ACCESS

Practice Questions: Breast Imaging

  1. 1. In operable invasive breast carcinoma undergoing upfront surgery, which axillary status supports sentinel lymph node biopsy?

    • A. Biopsy-proven axillary metastasis
    • B. Bulky palpable axillary nodes
    • C. Matted axillary lymph nodes
    • D. Clinically node-negative axilla
    Show answer

    Answer: D. Clinically node-negative axilla

    Clinically node-negative axilla supports sentinel lymph node biopsy for axillary staging in appropriately selected patients with operable invasive breast carcinoma undergoing upfront surgery. Biopsy-proven axillary metastasis establishes node-positive disease rather than the conventional node-negative staging indication. Bulky palpable axillary nodes require evaluation for nodal metastasis rather than routine sentinel staging of a clinically negative axilla. Matted axillary lymph nodes suggest advanced nodal involvement and do not meet this indication.

  2. 2. You are shown the screening mammogram of a 55-year-old woman. Which one of the following is the MOST likely diagnosis?

    • A. Fibroadenoma
    • B. Hematoma
    • C. Hamartoma
    • D. Galactocele
    • E. Oil cyst/Fat necrosis
    Show answer

    Answer: E. Oil cyst/Fat necrosis

    Oil cyst/Fat necrosis - Fat necrosis can form an oil cyst, a benign encapsulated collection of liquefied fat that appears as a round or oval radiolucent lesion. - A thin, well-defined rim, sometimes calcified over time, is characteristic; fat necrosis may follow trauma, surgery, radiation, or biopsy, or occur spontaneously. Fibroadenoma - Fibroadenoma is a benign fibrous and glandular tumor, most common in younger women, making it less likely in a 55-year-old woman. - Mammography usually shows a well-circumscribed, uniform-density mass, sometimes with coarse calcifications, rather than a radiolucent fatty lesion. Hematoma - Hematoma represents blood within breast tissue and is usually associated with trauma, biopsy, or surgery. - It more often appears as an increased-density or ill-defined mass with possible architectural distortion, unlike the characteristic radiolucent oil cyst. Galactocele - Galactocele is a milk-filled cyst that typically occurs during lactation or shortly after breastfeeding, which is unlikely in this 55-year-old woman. - It may show a fat-fluid level or variable-density circumscribed mass, not the thin-rimmed radiolucent appearance described here. Hamartoma - Hamartoma is a benign mixture of glandular, adipose, and fibrous tissues, producing a characteristic heterogeneous mass. - Its mammographic breast-within-a-breast or slice-of-lemon appearance differs from the purely radiolucent lesion of an oil cyst.

  3. 3. Which imaging modality is preferred for initial anatomical assessment of thoracic and abdominal metastases in breast cancer?

    • A. Ultrasonography
    • B. Plain radiography
    • C. Computed tomography
    • D. Magnetic resonance imaging
    Show answer

    Answer: C. Computed tomography

    Computed tomography is preferred for initial anatomical assessment of thoracic and abdominal metastases because it evaluates the lungs, liver and lymph nodes efficiently, usually with intravenous contrast. CT alone is not a complete whole-body staging strategy. Magnetic resonance imaging is valuable for selected sites but is not the routine first choice for simultaneous thoracic and abdominal assessment. Ultrasonography can assess liver lesions but cannot comprehensively evaluate pulmonary and mediastinal disease. Plain radiography is substantially less sensitive and cannot adequately stage abdominal metastases.

  4. 4. The Gail Model is used for risk assessment of which of the following?

    • A. Ovarian cancer
    • B. Breast cancer
    • C. Lung cancer
    • D. Prostate cancer
    Show answer

    Answer: B. Breast cancer

    Breast cancer - The Gail Model estimates a woman’s risk of developing invasive breast cancer, including five-year and lifetime risk, using personal and family history factors. - Relevant inputs include age, age at menarche, age at first live birth, breast biopsies or atypical hyperplasia, and first-degree relatives with breast cancer. Ovarian cancer - The Gail Model is not the standard tool for estimating ovarian cancer risk; assessment commonly involves BRCA1/2 testing and other hereditary-risk evaluation. - ROMA estimates the likelihood of malignancy in a patient with an existing adnexal mass; it does not predict future ovarian-cancer risk in an unaffected woman. Lung cancer - The Gail Model does not assess lung cancer risk because it was developed specifically for breast cancer risk prediction. - Lung-cancer screening decisions primarily consider smoking history, particularly cumulative pack-years, alongside eligibility for low-dose CT screening. Prostate cancer - The Gail Model is not used for prostate cancer risk assessment; it predicts invasive breast cancer risk in women using breast-related factors. - Prostate evaluation relies on factors such as PSA levels and clinical assessment, while IPSS measures urinary symptoms rather than cancer risk.

  5. 5. A 46-year-old woman has presenting visual acuity of 6/60 in the right eye and 3/60 in the left eye. Using WHO ICD-11 distance-acuity categories, how is her vision classified?

    • A. Moderate impairment
    • B. Severe vision impairment
    • C. Blindness
    • D. Mild vision impairment
    Show answer

    Answer: A. Moderate impairment

    Moderate impairment is correct because the better-eye presenting acuity is 6/60; moderate impairment is worse than 6/18 through 6/60 inclusive. Severe vision impairment requires acuity worse than 6/60 through 3/60 inclusive. Blindness requires acuity worse than 3/60. Mild vision impairment is worse than 6/12 through 6/18 inclusive, so the measured acuity is too poor for that category.

  6. 6. A 35-year-old woman presents with a rapidly enlarging palpable breast mass over the past 3 months. Mammography is performed. What is the most likely diagnosis?

    • A. Phyllodes tumor
    • B. Carcinoma breast
    • C. Galactocele
    • D. Fibroadenoma
    Show answer

    Answer: A. Phyllodes tumor

    Phyllodes tumor - A large, well-circumscribed, lobulated mass with increased density and possible calcifications supports a phyllodes tumor on mammography. - Phyllodes tumors are biphasic fibroepithelial tumors that commonly present in this age group as rapidly enlarging, often large palpable breast masses. Carcinoma breast - Invasive breast carcinoma more typically demonstrates spiculated margins, irregular shape, or architectural distortion rather than a smoothly circumscribed mass. - Although carcinoma can enlarge, the described well-circumscribed appearance and rapid growth favor phyllodes tumor over the usual mammographic pattern of carcinoma. Galactocele - A galactocele is a milk-filled cyst associated with lactation or recent pregnancy, neither of which is described in this 35-year-old woman. - Galactoceles usually appear as well-defined low-density lesions and would not typically produce the dense, solid-appearing components or rapid enlargement described here. Fibroadenoma - Fibroadenomas are generally smaller and less lobulated, although they may also appear as well-circumscribed breast masses. - Their growth is usually slower, and characteristic popcorn calcifications may be present; the rapid enlargement and large size instead suggest phyllodes tumor.

  7. 7. An MLO view of the left breast is shown. What is the MOST likely diagnosis?

    • A. Fibroadenomas
    • B. Papillomatosis
    • C. Fat necrosis
    • D. Simple breast cysts
    Show answer

    Answer: A. Fibroadenomas

    Fibroadenomas are supported by the circumscribed intraparenchymal masses and characteristic coarse popcorn calcification in the mammogram. Papillomatosis may be mammographically occult or produce masses and calcifications, sometimes with nipple discharge. Fine linear branching calcifications are suspicious for ductal carcinoma in situ rather than a characteristic benign papillomatosis pattern. Papillomatosis does not characteristically produce popcorn-calcified masses. Fat necrosis more typically produces fat-containing lesions, oil cysts, or rim calcification, although it can also mimic malignancy. Simple breast cysts can appear circumscribed on mammography, but ultrasound establishes their anechoic fluid content and they do not characteristically show popcorn calcification.

  8. 8. What is the investigation performed?

    • A. X-ray mammography
    • B. Breast MR imaging
    • C. Chest radiography
    • D. Breast ultrasonography
    Show answer

    Answer: A. X-ray mammography

    X-ray mammography - The paired compressed-breast projection radiographs are characteristic of mammography, which permits assessment of breast tissue, masses, and calcifications. - A dedicated breast X-ray unit uses compression paddles to spread tissue and improve visualization of masses and calcifications. Breast MR imaging - Breast MRI produces cross-sectional images in multiple planes, such as axial, sagittal, and coronal views, rather than compressed breast projections. - It commonly uses intravenous contrast to assess soft-tissue enhancement patterns, unlike the radiographic appearance shown here. Chest radiography - Plain chest radiography images the thoracic cavity, including the lungs, ribs, and mediastinum, usually in a standard chest projection. - It does not use specialized breast positioning and compression, which distinguish dedicated mammographic imaging from a chest X-ray. Breast ultrasonography - Breast ultrasonography produces sonographic sections using a transducer, rather than the compressed projection radiographs displayed here.

  9. 9. Sonographic scan shows:

    • A. Hydatidiform mole
    • B. Triplets
    • C. Twins
    • D. Single fetus
    Show answer

    Answer: B. Triplets

    Triplets are demonstrated by three separate gestational sacs, each containing a visible fetus. Hydatidiform mole typically produces an abnormal vesicular placental appearance rather than the three identifiable fetuses shown here. Twins would show two fetuses, not three. Single fetus would show only one fetus.

  10. 10. Which of the following is the most sensitive investigation for ductal carcinoma in situ (DCIS) of the breast?

    • A. PET Scan
    • B. Ultrasound
    • C. Mammography
    • D. MRI
    Show answer

    Answer: C. Mammography

    Mammography - Mammography is the gold standard and primary imaging modality for detecting ductal carcinoma in situ (DCIS), primarily because it excels at visualizing microcalcifications, which are the hallmark of DCIS. - Approximately 80-90% of DCIS cases present as microcalcifications on mammograms, making it the most important screening and diagnostic tool. - Mammography has high sensitivity (85-95%) for detecting DCIS, especially calcified forms, and is widely available and cost-effective. MRI - While MRI has high sensitivity for invasive breast cancer and can detect non-calcified DCIS, it is not the primary screening tool for DCIS detection. - MRI is typically used for staging known DCIS, evaluating extent of disease, detecting additional foci, and screening high-risk patients. - However, MRI has lower specificity and higher false-positive rates compared to mammography, limiting its use as a primary diagnostic tool. PET Scan - PET scans are generally not sensitive for detecting DCIS because DCIS lesions typically have a low metabolic rate and do not avidly take up the FDG tracer. - PET scans are primarily used for detecting invasive cancers and assessing metastatic disease, not for non-invasive lesions like DCIS. Ultrasound - Ultrasound has limited sensitivity for detecting DCIS because DCIS often does not present as a palpable mass or a distinct sonographic abnormality. - While ultrasound can be useful for evaluating palpable masses or guiding biopsies, it frequently misses microcalcifications that are characteristic of DCIS. - Ultrasound is mainly used as a complementary tool to mammography, not as a primary diagnostic modality for DCIS.

Flashcards: Breast Imaging

  1. 1. Most important sign of malignancy in mammogram is _____ _____ calcification

    Show answer

    clustered · micro

  2. 2. BIRADS is used for reporting

    Show answer

    all breast imaging

  3. 3. Mammography tube has a exit window and molybdenum filter

    Show answer

    beryllium

  4. 4. Sign of DCIS on MRI is a

    Show answer

    ductal enhancement.

  5. 5. The plastic shell of the breast implant can be seen floating within the silicon, producing a wavy line or _____ sign in MRI of _____capsular implant rupture

    Show answer

    linguini · intra

  6. 6. The following imaging on mammography represents a _____

    Show answer

    fibroadenoma

  7. 7. The following imaging on mammography represents a _____

    Show answer

    fat necrosis

  8. 8. The following imaging on mammography represents a _____

    Show answer

    DCIS

  9. 9. BIRADS _____ is defined as highly suggestive of malignancy (>95% malignant) and the next step is _____

    Show answer

    5 · biopsy

Everything you need for Indian Medical PG prep

Get full Oncourse access with lessons, practice questions, flashcards and AI study tools.

GET STARTED FOR FREE
75% OFFLimited time offer
GET 75% OFF